超声在评估合并纤维肌痛的银屑病关节炎患者中的作用
结果显示合并FMS者临床复合活动指数评分显著升高,但超声总评分及其亚类与无FMS者相似;超声总评分仅在无FMS组与CPDAI、DAPSA、PASDAS显著相关。结论提示超声在评估合并FMS的PsA患者疾病活动度方面显著优于临床复合评分。
要点
- 合并FMS的PsA患者临床复合活动指数评分显著升高,但超声评分与无FMS者相似。
- 超声总评分仅在无FMS的PsA组与CPDAI、DAPSA、PASDAS显著相关。
- 多变量线性回归显示FMS与临床评分升高显著相关,但与超声评分无关。
核心结论
- 在合并纤维肌痛综合征的银屑病关节炎患者中,超声评估疾病活动度的价值显著高于临床复合评分。
研究设计与样本
- 前瞻性纳入156例符合ClASsification criteria for Psoriatic ARthritis标准的连续银屑病关节炎患者,均完成临床评估(含2016年纤维肌痛分类标准)及超声评估(52个关节、40条肌腱、14个附着点),超声评分由对临床数据不知情的超声医师完成。
主要发现
- 合并与未合并FMS的两组患者超声总评分及其亚类相似。
- 超声总评分在无FMS的PsA组与CPDAI、DAPSA、PASDAS显著相关(p<0.001),但在合并FMS的PsA组无此相关。
- 多变量线性回归模型显示FMS与更高的临床评分显著相关(p<0.001),但与超声评分无显著关联。
关键数值与推荐
- 研究纳入156例连续PsA患者,均符合ClASsification criteria for Psoriatic ARthritis标准。
- FMS采用2016年纤维肌痛分类标准评估。
- 超声评估覆盖52个关节、40条肌腱和14个附着点,评分为半定量评分(包括滑膜炎、腱鞘炎和附着点炎)之和。
临床怎么用
- 对合并纤维肌痛的PsA患者,临床复合活动指数可能高估疾病活动度,超声可作为更客观的评估工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether ultrasonography (US), as an objective imaging modality, can optimise the evaluation of disease activity in psoriatic arthritis (PsA) patients with concomitant fibromyalgia syndrome (FMS). METHODS: The study population included 156 consecutive PsA patients who were recruited prospectively and fulfilled the ClASsification criteria for Psoriatic ARthritis criteria. The patients underwent complete clinical evaluation including assessment of fulfilment of the 2016 fibromyalgia classification criteria. All of the patients underwent US evaluation including 52 joints, 40 tendons and 14 entheses. The US score was based on the summation of a semiquantitative score (including synovitis, tenosynovitis and enthesitis). Scoring was performed by a sonographer blinded to the clinical data. Spearman's correlation coefficient and multivariate linear regression models were used to examine the association of FMS with clinical and the US scores. RESULTS: Forty-two patients (26.9%) with coexisting PsA and FMS were compared with 114 (73.1%) PsA patients without FMS. Patients with PsA and FMS had significantly increased scores for clinical composite indices, including non-Minimal Disease Activity, Composite Psoriatic Disease Activity Index (CPDAI), Disease Activity for Psoriatic Arthritis (DAPSA) and Psoriatic Arthritis Disease Activity Score (PASDAS) (p<0.001). In contrast, the total US score and its subcategories were similar for those with and without FMS. The total US score significantly correlated with CPDAI, DAPSA and PASDAS (p<0.001) in the PsA without FMS but not in the PsA with FMS group. FMS was significantly associated with higher clinical scores (p<0.001) but not with the US score (multivariable linear regression models). CONCLUSIONS: US has significantly greater value than composite clinical scores in the assessment of disease activity in PsA patients with FMS.
引用
- Polachek A, Furer V, Zureik M, et al. Role of ultrasound for assessment of psoriatic arthritis patients with fibromyalgia. Ann Rheum Dis. 2021. PMID: 34215648. doi:10.1136/annrheumdis-2021-220562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。